Pomponio, R.J., Reynolds, T.R., Cole, H., Buck, G.A., Wolf, B., Mutational hotspot in the human biotinidase gene causes profound biotinidase deficiency (1995) Nat Genet, 11, pp. 96-98
Pindolia, K., Jordan, M., Wolf, B., Analysis of mutations causing biotinidase deficiency (2010) Human Mutation, 31, pp. 983-991
Procter, M., Wolf, B., Crockett, D.K., Mao, R., The biotinidase gene variants registry. A paradigm public database (2013) G3 (Bethesda), 3, pp. 727-731
Wolf, B., Biotinidase deficiency: If you have to have an inherited metabolic disease, this is the one to have' (2012) Genetics in Medicine: Official Journal of the American College of Medical Genetics, 14, pp. 565-575
Li, H., Spencer, L., Nahhas, F., Novel mutations causing biotinidase deficiency in individuals identified by newborn screening in Michigan including an unique intronic mutation that alters mRNA expression of the biotinidase gene (2014) Molecular Genetics and Metabolism, 112, pp. 242-246
Senanayake, D.N., Jasinge, E.A., Pindolia, K., First contiguous gene deletion causing biotinidase deficiency: The enzyme deficiency in three Sri Lankan children (2015) Molecular Genetics and Metabolism Reports, 2, pp. 81-84
Wolf, B., Worldwide survey of neonatal screening for biotinidase deficiency (1991) Journal of Inherited Metabolic Disease, 14, pp. 923-927
Norrgard, K.J., Pomponio, R.J., Swango, K.L., Mutation (Q456H) is the most common cause of profound biotinidase deficiency in children ascertained by newborn screening in the United States (1997) Biochem Mol Med, 61, pp. 22-27
Pomponio, R.J., Hymes, J., Reynolds, T.R., Mutations in the human biotinidase gene that cause profound biotinidase deficiency in symptomatic children: Molecular, biochemical, and clinical analysis (1997) Pediatr Res, 42, pp. 840-848
Pagon, R.A., Bird, T.D., Dolan, C.R., (2013) Wolf BBiotinidase Deficiencyin, , GeneReviews [Internet]. University of Washington: Seattle: Seattle (WA), 1993-2013, [Last Update ]
Dobrowolski, S.F., Angeletti, J., Banas, R.A., Naylor, E.W., Real time PCR assays to detect common mutations in the biotinidase gene and application of mutational analysis to newborn screening for biotinidase deficiency (2003) Molecular Genetics and Metabolism, 78, pp. 100-107
Iqbal, F., Item, C.B., Vilaseca, M.A., The identification of novel mutations in the biotinidase gene using denaturing high pressure liquid chromatography (dHPLC) (2010) Molecular Genetics and Metabolism, 100, pp. 42-45
Cowan, T.M., Blitzer, M.G., Wolf, B., Technical standards and guidelines for the diagnosis of biotinidase deficiency (2010) Genetics in Medicine: Official Journal of the American College of Medical Genetics, 12, pp. 464-470
Thodi, G., Molou, E., Georgiou, V., Mutational analysis for biotinidase deficiency of a Greek patients' cohort ascertained through expanded newborn screening (2011) J Hum Genet, 56, pp. 861-865
Norrgard, K.J., Pomponio, R.J., Swango, K.L., Double mutation (A171T and D444H) is a common cause of profound biotinidase deficiency in children ascertained by newborn screening the the United States. Mutations in brief no. 128. Online (1998) Human Mutation, 11, p. 410
Loeber, J.G., Neonatal screening in Europe
The situation in 2004 (2007) Journal of Inherited Metabolic Disease, 30, pp. 430-438
Wolf, B., Grier, R.E., Allen, R.J., Goodman, S.I., Kien, C.L., Biotinidase deficiency: The enzymatic defect in late-onset multiple carboxylase deficiency (1983) Clin Chim Acta, 131, pp. 273-281
Wolf, B., Why screen newborns for profound and partial biotinidase deficiency? (2015) Molecular Genetics and Metabolism, 114, pp. 382-387
Bottin, L., Prud'Hon, S., Guey, S., Biotinidase deficiency mimicking neuromyelitis optica: Initially exhibiting symptoms in adulthood (2015) Mult Scler, 21, pp. 160-167
McVoy, J.R., Levy, H.L., Lawler, M., Partial biotinidase deficiency: Clinical and biochemical features (1990) J Pediatr, 116, pp. 78-83
Suormala, T.M., Baumgartner, E.R., Wick, H., Scheibenreiter, S., Schweitzer, S., Comparison of patients with complete and partial biotinidase deficiency: Biochemical studies (1990) Journal of Inherited Metabolic Disease, 13, pp. 76-92
Baykal, T., Gokcay, G., Gokdemir, Y., Asymptomatic adults and older siblings with biotinidase deficiency ascertained by family studies of index cases (2005) Journal of Inherited Metabolic Disease, 28, pp. 903-912
Muhl, A., Moslinger, D., Item, C.B., Stockler-Ipsiroglu, S., Molecular characterisation of 34 patients with biotinidase deficiency ascertained by newborn screening and family investigation (2001) Eur J Hum Genet, 9, pp. 237-243
Wolf, B., Clinical issues and frequent questions about biotinidase deficiency (2010) Molecular Genetics and Metabolism, 100, pp. 6-13
Neto, E.C., Schulte, J., Rubim, R., Newborn screening for biotinidase deficiency in Brazil: Biochemical and molecular characterizations (2004) Brazilian Journal of Medical and Biological Research=Revista Brasileira de Pesquisas Medicas e Biologicas/Sociedade Brasileira de Biofisica [Et Al], 37, pp. 295-299
Ohlsson, A., Guthenberg, C., Holme, E., Von Dobeln, U., Profound biotinidase deficiency: A rare disease among native Swedes (2010) Journal of Inherited Metabolic Disease, 33, pp. S175-S180
Tanzer, F., Sancaktar, M., Buyukkayhan, D., Neonatal screening for biotidinidase deficiency: Results of a 1-year pilot study in four cities in central Anatolia (2009) Journal of Pediatric Endocrinology & Metabolism: JPEM, 22, pp. 1113-1116
Heard, G.S., Secor McVoy, J.R., Wolf, B., A screening method for biotinidase deficiency in newborns (1984) Clinical Chemistry, 30, pp. 125-127
Jay, A.M., Conway, R.L., Feldman, G.L., Nahhas, F., Spencer, L., Wolf, B., Outcomes of individuals with profound and partial biotinidase deficiency ascertained by newborn screening in Michigan over 25 years (2015) Genetics in Medicine: Official Journal of the American College of Medical Genetics, 17, pp. 205-209
Tezel, B., Dilli, D., Bolat, H., The development and organization of newborn screening programs in Turkey (2014) Journal of Clinical Laboratory Analysis, 28, pp. 63-69
Lara, M.T., Gurgel-Giannetti, J., Aguiar, M.J., High Incidence of Biotinidase Deficiency from a Pilot Newborn Screening Study in Minas Gerais, Brazil (2015) JIMD Reports, 24, pp. 103-107
Carroll, A.E., Downs, S.M., Comprehensive cost-utility analysis of newborn screening strategies (2006) Pediatrics, 117, pp. S287-S295
Schoos, R., Verloes, A., Bourguignon, J.P., Koulischer, L., Programs of systematic screening in neonatology. Pharmaco-economic aspects (1998) Revue Medicale de Liege, 53, pp. 311-315
Swango, K.L., Demirkol, M., Huner, G., Partial biotinidase deficiency is usually due to the D444H mutation in the biotinidase gene (1998) Human Genetics, 102, pp. 571-575
Mock, D.M., Mock, N.I., Stewart, C.W., LaBorde, J.B., Hansen, D.K., Marginal biotin deficiency is teratogenic in ICR mice (2003) The Journal of Nutrition, 133, pp. 2519-2525
Said, H.M., Biotin: Biochemical, physiological and clinical aspects (2012) Sub-cellular Biochemistry, 56, pp. 1-19
Watanabe, T., Teratogenic effects of biotin deficiency in mice (1983) The Journal of Nutrition, 113, pp. 574-581
Zempleni, J., Mock, D.M., Marginal biotin deficiency is teratogenic (2000) Proceedings of the Society for Experimental Biology and Medicine Society for Experimental Biology and Medicine, 223, pp. 14-21
